ArticleOncotarget2016

Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.

Haibo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.